
Extended Follow-Up of the Safety of 131I Radiolabelled Anti-CD25 Antibody, Basiliximab, in Patients with CD25-Positive, Refractory Hodgkin Lymphoma
New Drugs
October 26, 2010
Further Lectures


Intensified ABVD for Newly Diagnosed Patients with Advanced-Stage Classical Hodgkin’s Lymphoma
Advanced Stages

PET assessment of residual tissue in advanced-stage HL: Final analysis of the HD15-PET trial
Advanced Stages

FDG-PET in the Design of Involved node Radiotherapy
PET
Infos
Congress: | 8th International Symposium on Hodgkin Lymphoma |
---|---|
Presenter: | N. Bhatnagar |
Category: | Cancer; Therapeutics; Hematology; Oncology; Lymphoma; lymphoma; Hodgkin lymphoma; Therapy; |